Under the BioVersys and GSK collaboration agreement, AlpE clinical development advances with first patient dosed in Phase 2b trial within UNITE4TB, following completion of a Phase 2a in adults with ...

A new report from the Centers for Disease Control and Prevention on the deadly drug-resistant bacteria NDM-CRE found a 70% rise in infections in the U.S. between 2019 and 2023. Also known as ...

这只是人工智能如何开启新药研发新时代的其中一个例子——它正为当代最棘手的医疗难题带来突破性进展。科学家现正将人工智能用于研究尚无已知疗法的疾病，如帕金森症及数千种罕见疾病，希望找到新的突破。